Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07371234 · RECRUITING
Trial details
- NCT number
- NCT07371234
- Sponsor
- Xiwei XU
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2027-01-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.